We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$988M
AUM Growth
-$950M
Cap. Flow
-$941M
Cap. Flow %
-95.22%
Top 10 Hldgs %
46.58%
Holding
205
New
16
Increased
16
Reduced
38
Closed
131

Top Buys

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$23.5M
2
OM icon
Outset Medical
OM
+$11.4M
3
LIVN icon
LivaNova
LIVN
+$8.76M
4
CUTR
Cutera, Inc.
CUTR
+$5.89M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$4.31M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$26.8M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$25.3M
3
BIIB icon
Biogen
BIIB
+$17.4M
4
ESTA icon
Establishment Labs
ESTA
+$15.9M
5
VRAY
ViewRay, Inc.
VRAY
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.61%
2 Industrials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HZNP
201
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-12,900
Closed -$1.47M
MACK
202
CALL
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-40,200
Closed -$461K
MACK
203
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-64,100
Closed -$735K
DENT
204
CALL
DELISTED
AdvisorShares Dent Tactical ETF
DENT
– –
-2,250,000
Closed -$15.7M
INBX
205
DELISTED
Inhibrx, Inc. Common Stock
INBX
– –
-93,575
Closed -$2.31M
5 6 7 8
9

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2023 Portfolio in Review

As of Q1 2023, Pura Vida Investments held 205 positions worth $988M, down 49% from $1.94B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments withdrew a net $941M in Q1 2023, closing 131 positions and reducing 38 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $25.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Industrials.

Against the trend, Pura Vida Investments opened a new position in Repligen worth $2.56M.

  • Pura Vida Investments's largest Q1 2023 buy was Repligen: 15,200 shares worth $2.56M.
  • Pura Vida Investments added most to Quanterix in Q1 2023, an estimated $23.5M increase.
  • Pura Vida Investments's biggest Q1 2023 reduction was Inspire Medical Systems, cutting an estimated $26.8M.
  • Pura Vida Investments fully exited IVERIC bio, Inc. Common Stock in Q1 2023, selling an estimated $25.3M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $988M portfolio in Q1 2023.
  • Pura Vida Investments opened 16 new positions and closed 131 in Q1 2023.
  • Pura Vida Investments's portfolio value fell 49% quarter-over-quarter to $988M.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.